Novo Nordisk A/S (NVO)
46.94
+0.20
(+0.44%)
USD |
NYSE |
Aug 24, 16:00
47.05
+0.10
(+0.22%)
After-Hours: 20:00
Novo Nordisk Max Drawdown (5Y) : 74.70% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 74.70% |
| June 30, 2026 | 74.70% |
| May 31, 2026 | 74.70% |
| April 30, 2026 | 74.70% |
| March 31, 2026 | 74.70% |
| February 28, 2026 | 73.71% |
| January 31, 2026 | 68.48% |
| December 31, 2025 | 68.48% |
| November 30, 2025 | 68.48% |
| October 31, 2025 | 68.48% |
| September 30, 2025 | 68.48% |
| August 31, 2025 | 68.48% |
| July 31, 2025 | 67.31% |
| June 30, 2025 | 59.66% |
| May 31, 2025 | 59.66% |
| April 30, 2025 | 59.66% |
| March 31, 2025 | 52.65% |
| February 28, 2025 | 46.79% |
| January 31, 2025 | 46.23% |
| December 31, 2024 | 41.92% |
| November 30, 2024 | 31.80% |
| October 31, 2024 | 23.65% |
| September 30, 2024 | 23.65% |
| August 31, 2024 | 23.65% |
| July 31, 2024 | 23.65% |
| Date | Value |
|---|---|
| June 30, 2024 | 23.65% |
| May 31, 2024 | 23.65% |
| April 30, 2024 | 23.65% |
| March 31, 2024 | 23.65% |
| February 29, 2024 | 23.65% |
| January 31, 2024 | 23.65% |
| December 31, 2023 | 23.65% |
| November 30, 2023 | 23.65% |
| October 31, 2023 | 23.81% |
| September 30, 2023 | 26.66% |
| August 31, 2023 | 26.66% |
| July 31, 2023 | 26.66% |
| June 30, 2023 | 26.66% |
| May 31, 2023 | 26.66% |
| April 30, 2023 | 26.66% |
| March 31, 2023 | 26.66% |
| February 28, 2023 | 26.66% |
| January 31, 2023 | 26.66% |
| December 31, 2022 | 26.66% |
| November 30, 2022 | 26.66% |
| October 31, 2022 | 26.66% |
| September 30, 2022 | 26.66% |
| August 31, 2022 | 26.66% |
| July 31, 2022 | 28.38% |
| June 30, 2022 | 28.38% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AstraZeneca PLC | 27.87% |
| Johnson & Johnson | 18.44% |
| Eli Lilly & Co. | 34.47% |
| Merck & Co., Inc. | 43.45% |
| Novartis AG | 20.42% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -8.149 |
| Beta (5Y) | 0.7554 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 37.95% |
| Historical Sharpe Ratio (5Y) | -0.0315 |
| Historical Sortino (5Y) | -0.0435 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.48% |